Under the auspices of His Excellency the Minister of Health and Population, the presence of the Presidential Adviser on Health and Prevention, the heads of health agencies and the representative of the World Health Organization in Egypt, and the participation of the Director of the Anti-microbial Unit of the African Centers for Disease Control and Prevention, Online.
The Egypt Healthcare Authority is launching the second medical conference to optimize anti-microbial and anti-infection use.
Adviser to the President of the Republic on health and prevention: the safe use of anti-microbial is imperative to eliminate resistance to bacteria. It confirms pharmaceutical innovation that contributes to the fight against bacterial resistance.
Adviser to the President of the Republic on Health and Prevention: Egypt has great potential and distinguished cadres that have eliminated schistosomiasis, polio, hepatitis and turned the Corona pandemic into a severe letter.
The head of the Egypt Healthcare Authority announces the selection of the 'Medical Ismailia as the first center of excellence to reduce anti-microbial resistance in hospitals in the departments of Universal health insurance.
Chairman of the Egypt Healthcare Authority: Publication of the results of scientific research at the Ismailia Medical Complex in the world scientific journals and periodicals. We look forward to sharing our knowledge and experience with all to achieve our common goals in enhancing patient safety and improving the quality of health care. The Welfare Authority has been placed on the map of scientific research for health care and global health systems
Chairman of the Egypt Healthcare Authority: We have been successful in reporting over 70% anti-microbial resistance during the first half of this year within Egypt commitment to the Muscat Convention against Bacterial Resistance. We have a full surveillance system in 11 welfare hospitals in collaboration with the World Health Organization (WHO).
Chairman of the Egypt Healthcare Authority: Microbe resistance to antibiotics causes medical costs to rise by more than 30%, according to World Bank estimates. It will be the leading cause of death in 2050, according to WHO projections.
Head of the Egypt Healthcare Authority: rational use of anti-microbial is a joint responsibility of individuals, families, health workers and the State and private sectors. Appreciates the fruitful and ongoing cooperation of Pfizer with the Care Authority to promote access to reliable and safe health care in accordance with the latest global quality standards and innovations.
The representative of the World Health Organization in Egypt stresses the importance of health care in preventing the spread of anti-microbial resistance. It stresses the importance of a global response to the One Health principle
World Health Organization (WHO) representative in Egypt: The wrong use of anti-microbial is causing the death of 5 million people worldwide. It stresses the importance of a medical conference to exchange experiences in an important step to counter the unsafe use of antimicrobial.
The Director of the Antimicrobial Resistance Unit of the African Center for Disease Control and Prevention (CDC) (Online) commends Egypt's efforts to combat anti-microbial resistance and infection in health facilities.
It stresses the importance of strengthening regional and international cooperation to combat this global health challenge and to ensure a healthy future for future generations.
The Regional Director of Pfizer, Egypt, the Sudan and the Arab Mashreq States confirms cooperation with the Egypt Healthcare Authority in Egypt to combat anti-microbial resistance to raise awareness and address this global health threat.
Today, the Egypt Healthcare Authority launched the second medical conference for the optimal use of anti-microbial and anti-infection (AMR), which was organized by the Authority in cooperation with the Egyptian Pfizer Pharmaceuticals and Vitals Company.
The Conference is sponsored by H.E. Dr. Khaled Abd-elgfar, Minister of Health and Population, and attended by H.E. Dr. Mohamed Awad Taj-Elden,, Adviser to the President of the Republic on Health and Prevention (the Honorary President of the Conference), Dr. Ahmed El-Sobky, Chairman of the Egypt Healthcare Authority and the General Supervisor of the Universal Health Insurance and Decent Life Projects of the Ministry of Health and Population (the President of the Conference), Dr. Maha El-Rabat, former Minister of Health, Dr. Ahmed Taha, Chairman of the General Authority for Health Accreditation and Control, Dr. Naeima Al-S short, representative of the World Health Organization (WHO) in Egypt, Dr. Ahmed El-Shazly, Regional Director of Pfizer, Egypt, Sudan, and the Arab Mashreq al-Iraq, Dr. Amr Kandil, Assistant Minister of Health and Population for Preventive Affairs, and by Dr. Wendy Alma, Director of the Anti-Microbe Resistance Unit of the African Center for Disease Control and Prevention, CDC "Online."
In addition, there are a number of vice-presidents of health agencies, members of the Health Committee of the Council of Representatives, members of the Board of Directors of the Egypt Healthcare Authority, leaders and officials of central and public administrations and branches of the Authority, leaders and representatives of the Ministry of Health and Population, representatives of civil society, international experts, eminent personalities and various universities, specialties, including consultants, doctors, pharmacists and nurses, as well as senior officials of pharmaceutical companies involved in anti-microbial resistance control in one of the major hotels in Cairo.
During his statement to the Conference, Dr. Mohamed Awad Taj-Elden, Adviser to the President of the Republic on Health and Prevention, said that the safe use of anti-microbial was an imperative to eliminate bacterial resistance, noting that the rational use of drugs represented a shift towards protecting the patient from the harm caused by their irrational use, and that antibiotics must be used under medical supervision, where excessive use led to the emergence of an anti-microbial strain, such as the Covid pandemic.
Dr. Mohamed Awad Taj-Elden stressed the need for concerted efforts to counter the misuse of anti-microbial, improve public awareness and control of resistant organisms and implement evidence-based practices to prevent and control infection. Egypt had great potential and distinct cadres, where it had eliminated schistosomiasis, polio and hepatitis. It had also administered the Covid pandemic with extremely technicality, noting that of the more than 10 diseases that caused death worldwide, 4 were respiratory diseases. It was therefore necessary to make good use of anti-microbial, and to draw broad lines in every medical specialization in a scientific and similar way to the different countries of the world. He continued: We should aim at the manufacture of new and more effective medicines, since drug innovation contributed to combating bacterial resistance.
In his opening statement to the Conference, Dr. Ahmed El-Sobky, President of the Egypt Healthcare Authority, announced the selection of the Authority's Ismaili Medical Complex in Ismaili governorate as the first center of excellence to reduce anti-microbial resistance to help reduce the spread of anti-microbial resistance (AMR), in cooperation with the Egyptian pharmaceutical and biopharmaceutical company Pfizer, pointing out that the Authority's largest hospital in Egypt's Universal health insurance governorates was the Ismaili Medical Complex and one of the brightest points of the Care Authority's initiative was "the centers of excellence for optimal use of anti-microbial and anti-infection control."
He explained that a team of experts would monitor and identify the causes of anti-microbial resistance within the Ismailia medical complex, particularly in the intensive care units. The complex was to produce a report on the results of the research carried out within it to combat anti-microbial resistance, as well as training plans for medical teams to upgrade their competence, which would contribute to the development of the health services system and benefit patients and health personnel. The medical complex would also contribute to the development of the pilot protocols to combat anti-microbial resistance in all hospitals and medical centers of the Universal Health Insurance System in the various governorates of the Republic.
The results of that research would be published in regional and global scientific journals and periodicals in order to transfer expertise, as well as to participate in conferences on the strategy for the optimal and rational use of anti-microbial, which would contribute to strengthening the leadership of the welfare service and health-care system and place it on the map of scientific research for health care and global health systems.
According to Dr. Ahmed El-Sobky, the introduction of the program for the safe use of anti-microbial represents a new perspective for health care in Egypt. It is clear that resistance to antibiotics is one of the greatest risks to global health and food security due to their misuse when given to humans and animals. The treatment of increased infections has become less effective after the effectiveness of antibiotics, whose resistance to microbes leads to extended hospitalization, higher medical costs, estimated by the World Bank to be more than 30%, an increase in the mortality rate, with 1,270 million deaths per year directly, and an indirect death of 5 million people per year, estimated by the World Health Organization (WHO), noting that according to the organization projections, resistance to antibiotics will be the main cause of death in 2050.
He emphasized that the Welfare Authority had adopted a clear strategy and taken several steps on scientific grounds that had strengthened its successful course in providing safe health care to patients and reducing anti-microbial resistance. The most important of them was the Convention on the Declaration of the Shortest Clinical Governance, which ensured the rational use of antibiotics and the safe and effective use of medicines. It had also promoted surveillance and research through the establishment of a unit to evaluate the use of medicines and appropriate medicines, aimed at improving the quality and efficacy of medicines and reducing the misuse of medicines. Other units of vigilance, in coordination with the Egyptian Medicine Authority, had developed a strategy to reduce the risks of side effects and adverse drug reactions. In addition, it had taken several initiatives to raise public awareness of the optimal use of medicines, including a dose-of-awareness initiative for healthy medicine, as well as the initiative to control the use of drugs and rationalize the use of antibiotics to ensure the continued safety and efficacy of medicines, the full training of the health team, the implementation of evidence-based practices to prevent and control infection, the strengthening of surveillance and monitoring systems for early detection of resistance and infection, and the strengthening of international cooperation for the exchange of information and expertise in that would enhance safe care within its health facilities.
The program for the optimal use of antibiotics had been implemented through the Department of Pharmaceutical Affairs and the Department of Medicine. It had included the development of microbiological laboratories to identify and treat microbes accurately, the dissemination of scientific evidence for optimal use and the training of medical personnel, in order to complete the implementation of the strategy for the optimal use of antibiotics by all concerned parties in the health team, including doctors, pharmacists, technicians, microbiological laboratories, nurses and pharmacists.
In cooperation with the World Health Organization (WHO), a system of full monitoring is in place in 11 welfare hospitals. The program of points for optimal use of antibiotics is being implemented in more than 10 hospitals, in coordination with the Egyptian Medicine Authority. Moreover, in the context of Egypt commitment to the world with the Muscat agreement resulting from the Third World Ministerial Conference on Anti-microbial Resistance, the Authority health facilities submitted their reports on anti-microbial surveillance during the first half of this year.
He noted the efforts of the World Health Organization (WHO) and the Welfare Authority in developing operational plans for the implementation of the anti-microbial resistance program in health facilities, as part of the global approach to anti-microbial use, and the training of medical personnel to update them on global developments in that area, referring to training by the WHO team for the infection control team, doctors, pharmacists and microbiologists, for use by WHO in recording the results of the microbiological laboratories for the work of Anti-ogram. This is a compilation of all microbiological laboratories and results in optimum use of successful treatment and optimal use of antibiotics and resistant anti-microbial drugs, including documentation and compilation of the latest year to determine how to purchase antibiotics and how to develop therapeutic plans for each health plant and sections within them, thereby confirming the success and effectiveness of the use of antibiotics or anti-microbial in this plant and section, so that we would have used all kinds of strategies for the optimal use of anti-microbial according to global standards.
The rational use of anti-microbial was a shared responsibility of individuals, families, health workers and the State and private sectors. The second medical conference of the Welfare Authority for the optimal use of antibiotics and anti-infection was an ideal platform for the exchange of advanced expertise, knowledge, research and practical solutions. It was important to combine all efforts to achieve the goals of sustainable development, reduce resistance to antibiotics, promote innovation, increase investments in practical research and undertake research and development activities with regard to the development of anti-microbial medicines, vaccines and diagnostics and the fight against infection, in order to protect health, health security, health and development stability, and achieve a safe and dignified life.
Dr. Ahmed El-Sobky noted that the launch of this important conference was part of the commitment of the Egypt Healthcare Authority to strengthen the level of health care and to develop modern knowledge and practices in the use of anti-microbial and anti-infection. The conference brings together a variety of medical experts and stakeholders to give lectures, participate in fruitful discussions to exchange knowledge and experience and promote cooperation among doctors, pharmacists, nurses, researchers and specialists in this area. It is a great opportunity to communicate with each other in order to learn about the latest innovations and research in this important area.
We look forward to sharing our knowledge and experience with everyone through this pioneering anti-microbial and anti-infection initiative. We thank all the supporters and partners who contributed to this important event for achieving significant progress in our common goal of enhancing patient safety and improving the quality of health care. We also wish to refer to the international accreditation of the IGAD Specialized Hospital in Port-said as the first center of excellence within the global program for the optimal use of anti-microbial and anti-infection control.
Dr. Ahmed Al-El-Sobky valued the ongoing and fruitful cooperation with the Egyptian company Pfizer, affirming its success partner and commending the company community participation and responsibility and its continued cooperation in support of the successes of the Egypt Healthcare Authority to provide the best services and outstanding health care to the users of the universal health insurance. He stressed the importance of cooperation between the Government and private sectors in order to improve the health system and promote an investment climate in Egypt health sector, and of cooperation with health-care providers, Governments and communities with a view to supporting and promoting access to reliable and safe health care in accordance with the latest global standards of quality and innovation.
For her part, Dr. Naeima Al-Qusayr, representative of the World Health Organization (WHO), Egypt, during her statement at the second medical conference on the optimal use of anti-microbial and anti-infection, stressed the importance of the central role played by health care in preventing the emergence and spread of anti-microbial resistance, pointing out that the global nature of anti-retroviral resistance requires a global response in line with the One Health approach and that the optimal use of anti-microbial should be encouraged, warning of the risk of irrational use, and pointing out that the wrong use of anti-microbial is causing the death of 5 million global citizens.
She went on to stress the importance of a medical conference to exchange experiences among all in an important step in the implementation of national strategies to counter the unsafe use of anti-microbial and to protect the health of Egyptians from their dangers. She noted the importance of focusing on the full training of doctors, pharmacists and members of the health team concerned on the latest treatment protocols, particularly antibiotics, as well as increasing public awareness about their rational use. She stressed the importance of that, and pointed out that if there was resistance on the part of microbes and viruses to medicines, that posed a great risk and pandemic, as we saw in the Corona virus pandemic.
Dr. Wendy Alma, Director of the Antimicrobial Resistance Unit of the African Center for Disease Control and Prevention (CDC), through her participation, Online, stressed the importance of combating anti-microbial resistance and infection in health facilities, noting that it posed a global challenge to human health and called for Universal cooperation between States and health institutions. Egypt had taken important steps in that area, paying great attention to the issue and strengthening its capacity to combat anti-microbial resistance and infection in health facilities.
Dr. Wendy Alma explained that combating anti-microbial resistance required the implementation of systematic and Universal measures, including the promotion of awareness-raising and training for health personnel, the strengthening of national policies and guidance for responsible and effective use of anti-microbial drugs, the development of surveillance and monitoring systems for early detection of resistance and infection, and the strengthening of international cooperation for the exchange of information and experience in this area.
Alma was very impressed by the steps taken by Egypt and the Egypt Healthcare Authority to combat anti-microbial and anti-infection resistance. The country health facilities were working hard to achieve the highest standards of health quality and safety, noting that the Egypt Healthcare Authority had made significant progress in promoting counter-resistance awareness, implementing training programs for health personnel and strengthening cooperation with the concerned authorities.
She stressed the importance of continuing efforts to combat anti-microbial and anti-infection resistance and of strengthening domestic and international cooperation and partnerships in that regard, and called for intensified efforts, exchange of experience and knowledge to combat that global health challenge and ensure a healthy future for future generations.
For his part, Dr. Ahmed Taha, Chairman of the General Authority for Health Accreditation and Control, stressed that the standards for the management and safety of medicines issued by the General Authority for Health Accreditation and Control include 40 criteria divided into 22 for the control of infection, 18 for the management and circulation of medicines in health facilities, the most important of which is the standard of the program for the supervision of anti-health drugs, which aims to promote the safe and effective use of antibiotics. Health service providers must comply with the standards issued by the Authority, which guarantee the safety and security of patients, help to manage the use of antibiotics and change the behaviors of their prescription practices and provide unnecessary health-care costs, as well as strengthen control over the use of antibiotics in approved health facilities in accordance with quality standards.
Dr. Amr Kandil, Assistant Minister of Health and Population for Preventive Medicine, noted that, in the context of ongoing efforts to address public health challenges related to counter-resistance, the National Antibiotic Strategy had been launched as a decisive step to address the spread of anti-biotic microbes, which posed a global threat to health and medical treatments. It included several basic principles, notably the promotion of public awareness and education, the training of health professionals on the proper use of anti-microbial and the importance of reducing their unnecessary use, the promotion of research and development in biosciences and antibiotics, the strengthening of preventive measures and the control of infections. The National Anti-biotic Strategy was based on Universal cooperation between the Government, the health sector, researchers, academic institutions and civil society to achieve the objectives of combating counter-resistance, ensuring the health of society and the sustainability of medical treatments.
Dr. Ahmed El-Shazly, Regional Director of Pfizer, Egypt, Sudan, and the Arab Mashreq States, and Iraq, stressed the importance of public-private cooperation and coordination to address the challenge of anti-microbial resistance, noting the cooperation of Pfizer with the Egypt Healthcare Authority of Egypt and partners and institutions concerned with the health sector to raise awareness and promote best practices in the use of anti-microbial, combat infection and address this global threat.
Gay indicated that anti-microbial resistance posed a major challenge to the global health sector and required joint efforts to address it, particularly in the area of research and development. Pfizer had a long history of innovation and production of advanced anti-microbial and vaccines, and was continuing its efforts to overcome public health challenges and environmental problems resulting from anti-microbial resistance.
The conference program will include scientific presentations and detailed discussions on strategies to reduce anti-microbial resistance to health-care facilities, and the development of principles for the use of antibiotics in society, with A.د. Sharif Kamal, adviser to the head of the Department of Health Care for Pharmaceuticals and Drug Administration, as well as scientific presentations and discussions on improving the prevention and control of infection at these facilities, with Dr. Omar Talha, Director of the Authority's Infection Control Department.
